NCT06031207|Completed
Loading search results
Sponsor study identifier
observational
90
1 country
1
Study Start
September 1, 2023
Actual (reported)Primary Completion
December 20, 2023
Actual (reported)Study Completion
January 30, 2024
Actual (reported)The study will employ a Cross-Sectional Validation Study design. The study will be conducted at the Department of Physical Therapy, University of Lahore Teaching Hospital, located on Defence Road, Lahore. The anticipated duration of the study will be 09 months, commencing after the approval of the synopsis. The sample size will be determined following the Kline Method, resulting in a total of 90 participants. A Purposive Sampling Technique will be utilized to select the study participants.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 30, 2024
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 1, 2023
Actual (reported)September 3, 2023
Actual (reported)September 11, 2023
Actual (reported)December 20, 2023
Actual (reported)January 30, 2024
Actual (reported)Fatigue Severity Scale
The Fatigue Severity Scale (FSS) is a self-reported measure of fatigue and sleep disturbance in patients with fibromyalgia. It is a 9-item scale that assesses the severity of fatigue, the impact of fatigue on daily activities, and the degree of sleep disturbance. The FSS is a widely used instrument in research and clinical practice, and has been found to be a valid and reliable measure of fatigue and sleep disturbance in patients with fibromyalgia. The FSS items are rated on a 5-point Likert scale, with responses ranging from "not at all" to "extremely." The total score ranges from 0 to 36, with higher scores indicating greater levels of fatigue and sleep disturbance.
1 week
Multidimensional Fatigue Inventory
The Multidimensional Fatigue Inventory (MFI) is a self-report questionnaire designed to assess various dimensions of fatigue experienced by individuals. It is commonly used in research and clinical settings to measure and understand fatigue in different contexts. Respondents answer a series of questions related to each dimension on a Likert-type scale, typically ranging from 1 to 5 or 0 to 4. The scores from each dimension are summed to obtain subscale scores, and a total score is often calculated by summing all subscale scores. Higher scores indicate greater levels of fatigue.
1 week
Fibromyalgia is a disease characterized by chronic pain, stiffness, and tenderness of muscles, tendons, and joints, without detectable inflammation. Fibromyalgia does not cause body damage or deformity. Fatigue affects 90 percent of patients and sleep disorders are common. Patients diagnosed with fibromyalgia according to the American College of Rheumatology (ACR) criteria will be included in this study.
University of Lahore Teaching Hospital
Lahore, Punjab Province, 55150, Pakistan
Memona Khan, MSPT MSK*
University of Lahore
Hafiza Sana Ashraf, MSPT MSK
University of Lahore
90 participants (actual enrollment reported by the registry).
First Submitted
September 3, 2023
First Posted
September 11, 2023
Study Start
September 1, 2023
Actual (reported)Validity and Reliability of the 2-minute Step Test in Patients With Fibromyalgia
Contact the study team to confirm eligibility.
Primary Completion
December 20, 2023
Actual (reported)Study Completion
January 30, 2024
Actual (reported)Last Updated
August 11, 2025
Record last verified: 2023-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: